Adverse Maternal and Fetal/Neonatal Outcomes:
All women in both LVOTO/AS and control groups were asymptomatic at
baseline. There were no adverse maternal cardiac outcomes in the
LVOTO/AS group (Table 4). Two women in the control group had
supraventricular tachycardia during 2nd trimester of
their pregnancy (Table 4). Obstetrical outcomes were similar between the
two groups, although a trend to increased rate of gestational
hypertension, miscarriage, and pre-term deliveries were observed. Three
adverse fetal events occurred in the LVOTO/AS group and none in the
control group (Table 4).